Lisa Marshall

Lisa Marshall has a diverse work experience in the field of biotechnology. Lisa is currently working as a Principal Scientist at EpiBiologics since September 2022. Prior to this, they were a Senior Scientist II at Soteria Biotherapeutics from March 2021 to August 2022. Lisa also worked at RAPT Therapeutics as a Senior Scientist and Project Team Leader from August 2018 to March 2021, where they led a cross-functional project team in developing cancer immunotherapies and conducted in vivo tumor studies and PK/PD studies.

Before joining RAPT Therapeutics, Lisa held various positions at FLX Bio, Inc. from April 2015 to July 2018, including Scientist II and Senior Scientist and Project Team Leader. Lisa also worked as a Scientist at Flexus Biosciences from January 2014 to April 2015.

Lisa began their career at Amgen in 2004, where they worked as a Scientist and later as a Senior Associate Scientist until January 2014. During their time at Amgen, they focused on investigating human genetic mutations and managing research associates. Lisa was also an active member of the Target Discovery strategy team and evaluated technologies for the group.

Lisa started their journey in the biotechnology industry as an Associate Scientist at Tularik in 1993, where they gained initial experience before moving on to other positions.

Lisa Marshall attended Santa Clara University from 1989 to 1993, where they obtained a Bachelor of Science (BS) degree in Biology/Biological Sciences, General.